181 related articles for article (PubMed ID: 10514386)
1. Immunohistochemical analysis of uroplakins, urothelial specific proteins, in ovarian Brenner tumors, normal tissues, and benign and neoplastic lesions of the female genital tract.
Ogawa K; Johansson SL; Cohen SM
Am J Pathol; 1999 Oct; 155(4):1047-50. PubMed ID: 10514386
[TBL] [Abstract][Full Text] [Related]
2. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
3. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
Esheba GE; Longacre TA; Atkins KA; Higgins JP
Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
[TBL] [Abstract][Full Text] [Related]
4. Uroplakin III is a highly specific and moderately sensitive immunohistochemical marker for primary and metastatic urothelial carcinomas.
Kaufmann O; Volmerig J; Dietel M
Am J Clin Pathol; 2000 May; 113(5):683-7. PubMed ID: 10800401
[TBL] [Abstract][Full Text] [Related]
5. Uroplakin gene expression by normal and neoplastic human urothelium.
Lobban ED; Smith BA; Hall GD; Harnden P; Roberts P; Selby PJ; Trejdosiewicz LK; Southgate J
Am J Pathol; 1998 Dec; 153(6):1957-67. PubMed ID: 9846985
[TBL] [Abstract][Full Text] [Related]
6. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.
Soslow RA; Rouse RV; Hendrickson MR; Silva EG; Longacre TA
Int J Gynecol Pathol; 1996 Jul; 15(3):257-65. PubMed ID: 8811388
[TBL] [Abstract][Full Text] [Related]
7. Uroplakins and cytokeratins in the regenerating rat urothelium after sodium saccharin treatment.
Romih R; Jezernik K; Masera A
Histochem Cell Biol; 1998 Mar; 109(3):263-9. PubMed ID: 9541475
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Brenner tumors and Walthard nests: a histologic and immunohistochemical study.
Roma AA; Masand RP
Hum Pathol; 2014 Dec; 45(12):2417-22. PubMed ID: 25281026
[TBL] [Abstract][Full Text] [Related]
9. p63 expression in ovarian tumours: a marker for Brenner tumours but not transitional cell carcinomas.
Liao XY; Xue WC; Shen DH; Ngan HY; Siu MK; Cheung AN
Histopathology; 2007 Oct; 51(4):477-83. PubMed ID: 17880529
[TBL] [Abstract][Full Text] [Related]
10. Immunoprofile of ovarian tumors with putative transitional cell (urothelial) differentiation using novel urothelial markers: histogenetic and diagnostic implications.
Logani S; Oliva E; Amin MB; Folpe AL; Cohen C; Young RH
Am J Surg Pathol; 2003 Nov; 27(11):1434-41. PubMed ID: 14576476
[TBL] [Abstract][Full Text] [Related]
11. Ovarian Brenner tumour: a morphologic and immunohistochemical analysis suggesting an origin from fallopian tube epithelium.
Kuhn E; Ayhan A; Shih IeM; Seidman JD; Kurman RJ
Eur J Cancer; 2013 Dec; 49(18):3839-49. PubMed ID: 24012099
[TBL] [Abstract][Full Text] [Related]
12. Uroplakins as markers of urothelial differentiation.
Sun TT; Liang FX; Wu XR
Adv Exp Med Biol; 1999; 462():7-18; discussion 103-14. PubMed ID: 10599409
[No Abstract] [Full Text] [Related]
13. Formation of asymmetric unit membrane during urothelial differentiation.
Sun TT; Zhao H; Provet J; Aebi U; Wu XR
Mol Biol Rep; 1996; 23(1):3-11. PubMed ID: 8983014
[TBL] [Abstract][Full Text] [Related]
14. Uroplakins, specific membrane proteins of urothelial umbrella cells, as histological markers of metastatic transitional cell carcinomas.
Moll R; Wu XR; Lin JH; Sun TT
Am J Pathol; 1995 Nov; 147(5):1383-97. PubMed ID: 7485401
[TBL] [Abstract][Full Text] [Related]
15. Inverse expression of uroplakins and inducible nitric oxide synthase in the urothelium of patients with bladder outlet obstruction.
Romih R; Korosec P; Jezernik K; Sedmak B; Trsinar B; Deng FM; Liang FX; Sun TT
BJU Int; 2003 Apr; 91(6):507-12. PubMed ID: 12656904
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of four uroplakins in urothelial preneoplastic lesions.
Zupančič D; Zakrajšek M; Zhou G; Romih R
Histochem Cell Biol; 2011 Oct; 136(4):491-500. PubMed ID: 21853341
[TBL] [Abstract][Full Text] [Related]
17. Specific heterodimer formation is a prerequisite for uroplakins to exit from the endoplasmic reticulum.
Tu L; Sun TT; Kreibich G
Mol Biol Cell; 2002 Dec; 13(12):4221-30. PubMed ID: 12475947
[TBL] [Abstract][Full Text] [Related]
18. Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease.
Stahlschmidt J; Varley CL; Toogood G; Selby PJ; Southgate J
Kidney Int; 2005 Sep; 68(3):1032-40. PubMed ID: 16105033
[TBL] [Abstract][Full Text] [Related]
19. Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?
Riedel I; Liang FX; Deng FM; Tu L; Kreibich G; Wu XR; Sun TT; Hergt M; Moll R
Eur J Cell Biol; 2005 Mar; 84(2-3):393-405. PubMed ID: 15819416
[TBL] [Abstract][Full Text] [Related]
20. Differential immunocytochemical staining patterns of uroplakin observed on neoplastic and nonneoplastic tissue fragments obtained from upper urinary tract brush specimens.
Xu X; Genega EM; Nasuti JF
Acta Cytol; 2002; 46(4):684-9. PubMed ID: 12146031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
